TOP2A and prostate cancer: Several of the transcripts identified in the CTCs have been correlated with aggressive behavior in localized prostate cancer (e.g. PLK-1, TOP2A) so it is interesting to observe these markers in cells from patients with highly advanced prostate cancers [39], [40].